Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT00085345 · WITHDRAWN

Trial details

NCT number: NCT00085345
Sponsor: Oncotherapeutics
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Stage II Multiple Myeloma Stage III Multiple Myeloma Refractory Plasma Cell Neoplasm

Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.